Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders

Overview

Journal Antioxidants (Basel)

Date 2022 Mar 25

PMID 35326205

Authors

Stefan W Ryter

Affiliations

Soon will be listed here.

Abstract

The heme oxygenase (HO) enzyme system catabolizes heme to carbon monoxide (CO), ferrous iron, and biliverdin-IXα (BV), which is reduced to bilirubin-IXα (BR) by biliverdin reductase (BVR). HO activity is represented by two distinct isozymes, the inducible form, HO-1, and a constitutive form, HO-2, encoded by distinct genes (, , respectively). HO-1 responds to transcriptional activation in response to a wide variety of chemical and physical stimuli, including its natural substrate heme, oxidants, and phytochemical antioxidants. The expression of HO-1 is regulated by NF-E2-related factor-2 and counter-regulated by Bach-1, in a heme-sensitive manner. Additionally, promoter polymorphisms have been associated with human disease. The induction of HO-1 can confer protection in inflammatory conditions through removal of heme, a pro-oxidant and potential catalyst of lipid peroxidation, whereas iron released from HO activity may trigger ferritin synthesis or ferroptosis. The production of heme-derived reaction products (i.e., BV, BR) may contribute to HO-dependent cytoprotection via antioxidant and immunomodulatory effects. Additionally, BVR and BR have newly recognized roles in lipid regulation. CO may alter mitochondrial function leading to modulation of downstream signaling pathways that culminate in anti-apoptotic, anti-inflammatory, anti-proliferative and immunomodulatory effects. This review will present evidence for beneficial effects of HO-1 and its reaction products in human diseases, including cardiovascular disease (CVD), metabolic conditions, including diabetes and obesity, as well as acute and chronic diseases of the liver, kidney, or lung. Strategies targeting the HO-1 pathway, including genetic or chemical modulation of HO-1 expression, or application of BR, CO gas, or CO donor compounds show therapeutic potential in inflammatory conditions, including organ ischemia/reperfusion injury. Evidence from human studies indicate that HO-1 expression may represent a biomarker of oxidative stress in various clinical conditions, while increases in serum BR levels have been correlated inversely to risk of CVD and metabolic disease. Ongoing human clinical trials investigate the potential of CO as a therapeutic in human disease.

Citing Articles

Antioxidant and Anti-Inflammatory Activities of Methanol Extract of (Viv.) H.S. Irwin & Barneby Through Nrf2/HO-1-Mediated Inhibition of NF-κB Signaling in LPS-Stimulated Mouse Microglial Cells.

Lim J, Li X, Lee D, Yao L, Yoo G, Kim Y Int J Mol Sci. 2025; 26(5).

PMID: 40076558 PMC: 11900505. DOI: 10.3390/ijms26051932.

Effects and Mechanisms of Imperatorin on Vitrified Mouse Oocytes.

Feng Y, Zhang M, Yuan W, Zhao D, Luo Z, Tang Z Animals (Basel). 2025; 15(5).

PMID: 40075944 PMC: 11898152. DOI: 10.3390/ani15050661.

Chronic Wound Initiation: Single-Cell RNAseq of Cutaneous Wound Tissue and Contributions of Oxidative Stress to Initiation of Chronicity.

Jabbari P, Kim J, Le B, Zhang W, Zhang H, Martins-Green M Antioxidants (Basel). 2025; 14(2).

PMID: 40002400 PMC: 11852160. DOI: 10.3390/antiox14020214.

Crosstalk Between Antioxidants and Adipogenesis: Mechanistic Pathways and Their Roles in Metabolic Health.

Fu M, Yoon K, Ha J, Kang I, Choe W Antioxidants (Basel). 2025; 14(2).

PMID: 40002389 PMC: 11852089. DOI: 10.3390/antiox14020203.

Antioxidative Function of Zinc and Its Protection Against the Onset and Progression of Kidney Disease Due to Cadmium.

Satarug S Biomolecules. 2025; 15(2).

PMID: 40001486 PMC: 11853145. DOI: 10.3390/biom15020183.

References

McClung J, Levy L, Garcia V, Stec D, Peterson S, Abraham N . Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications. Pharmacol Ther. 2021; 231:107975. PMC: 8958338. DOI: 10.1016/j.pharmthera.2021.107975. View

Cao J, Sodhi K, Inoue K, Quilley J, Rezzani R, Rodella L . Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. Hum Gene Ther. 2010; 22(3):271-82. PMC: 3057195. DOI: 10.1089/hum.2010.059. View

Ishikawa K, Navab M, Lusis A . Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice. Int J Hypertens. 2012; 2012:948203. PMC: 3296294. DOI: 10.1155/2012/948203. View

Du J, Ren W, Zhang Q, Fu N, Han F, Cui P . Heme Oxygenase-1 Suppresses Wnt Signaling Pathway in Nonalcoholic Steatohepatitis-Related Liver Fibrosis. Biomed Res Int. 2020; 2020:4910601. PMC: 7212281. DOI: 10.1155/2020/4910601. View

Medina M, Sapochnik D, Garcia Sola M, Coso O . Regulation of the Expression of Heme Oxygenase-1: Signal Transduction, Gene Promoter Activation, and Beyond. Antioxid Redox Signal. 2019; 32(14):1033-1044. PMC: 7153632. DOI: 10.1089/ars.2019.7991. View

Nagao S, Taguchi K, Sakai H, Tanaka R, Horinouchi H, Watanabe H . Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis. Biomaterials. 2014; 35(24):6553-62. DOI: 10.1016/j.biomaterials.2014.04.049. View

Kaizu T, Ikeda A, Nakao A, Tsung A, Toyokawa H, Ueki S . Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation. Am J Physiol Gastrointest Liver Physiol. 2007; 294(1):G236-44. DOI: 10.1152/ajpgi.00144.2007. View

Fleischhacker A, Gunawan A, Kochert B, Liu L, Wales T, Borowy M . The heme-regulatory motifs of heme oxygenase-2 contribute to the transfer of heme to the catalytic site for degradation. J Biol Chem. 2020; 295(16):5177-5191. PMC: 7170523. DOI: 10.1074/jbc.RA120.012803. View

MacGarvey N, Suliman H, Bartz R, Fu P, Withers C, Welty-Wolf K . Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis. Am J Respir Crit Care Med. 2012; 185(8):851-61. PMC: 3360573. DOI: 10.1164/rccm.201106-1152OC. View

10.

Wenzel P, Rossmann H, Muller C, Kossmann S, Oelze M, Schulz A . Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans. Eur Heart J. 2015; 36(48):3437-46. DOI: 10.1093/eurheartj/ehv544. View

11.

Liu X, Pachori A, Ward C, Davis J, Gnecchi M, Kong D . Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB J. 2006; 20(2):207-16. DOI: 10.1096/fj.05-4435com. View

12.

Alam J, Cook J . How many transcription factors does it take to turn on the heme oxygenase-1 gene?. Am J Respir Cell Mol Biol. 2006; 36(2):166-74. DOI: 10.1165/rcmb.2006-0340TR. View

13.

Lee P, Choi A . Pathways of cell signaling in hyperoxia. Free Radic Biol Med. 2003; 35(4):341-50. DOI: 10.1016/s0891-5849(03)00279-x. View

14.

Zhang C, Liu S, Yang M . Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options. Front Endocrinol (Lausanne). 2022; 12:808526. PMC: 8733382. DOI: 10.3389/fendo.2021.808526. View

15.

Weaver L, Hamoud A, Stec D, Hinds Jr T . Biliverdin reductase and bilirubin in hepatic disease. Am J Physiol Gastrointest Liver Physiol. 2018; 314(6):G668-G676. PMC: 6032063. DOI: 10.1152/ajpgi.00026.2018. View

16.

Liu X, Wei J, Peng D, Layne M, Yet S . Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. Diabetes. 2005; 54(3):778-84. DOI: 10.2337/diabetes.54.3.778. View

17.

Shahcheraghi S, Salemi F, Peirovi N, Ayatollahi J, Alam W, Khan H . Nrf2 Regulation by Curcumin: Molecular Aspects for Therapeutic Prospects. Molecules. 2022; 27(1). PMC: 8746993. DOI: 10.3390/molecules27010167. View

18.

Igarashi K, Nishizawa H, Saiki Y, Matsumoto M . The transcription factor BACH1 at the crossroads of cancer biology: From epithelial-mesenchymal transition to ferroptosis. J Biol Chem. 2021; 297(3):101032. PMC: 8387770. DOI: 10.1016/j.jbc.2021.101032. View

19.

Hashiba T, Suzuki M, Nagashima Y, Suzuki S, Inoue S, Tsuburai T . Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther. 2001; 8(19):1499-507. DOI: 10.1038/sj.gt.3301540. View

20.

Gibbs P, Miralem T, Maines M . Biliverdin reductase: a target for cancer therapy?. Front Pharmacol. 2015; 6:119. PMC: 4452799. DOI: 10.3389/fphar.2015.00119. View